Abstract
Get full access to this article
View all access options for this article.
References
1.
Total capital disclosed by RareCyte last year. Company at deadline had not responded to GEN queries seeking an updated total capital raised figure.
2.
Total capital disclosed by the company in the February 23, 2022, announcement of Spatial Genomics' Series A financing. The company at deadline had not responded to GEN queries about any subsequent additional financing.